TELA Bio (TELA) Receivables (2018 - 2026)

TELA Bio's Receivables history runs 9 years deep, the most recent figure standing at $9.7 million for Q1 2026.

• On a quarterly basis, Receivables fell 7.98% year-over-year to $9.7 million in Q1 2026; TTM through Mar 2026 was $9.7 million, a 7.98% decrease from a year earlier, with the FY2025 full-year figure at $10.3 million, up 2.47% from the prior year.
• Receivables declined to $9.7 million in Q1 2026 per TELA's latest filing, from $10.3 million in the prior quarter.
• Across five years, Receivables topped out at $11.3 million in Q3 2025 and bottomed at $4.3 million in Q1 2022.
• The 5-year median for Receivables is $9.7 million (2026), against an average of $8.7 million.
• Across the five-year window, Receivables soared 59.19% in 2022 and slipped 7.98% in 2026, its largest moves.
• Year by year, Receivables stood at $6.6 million in 2022, then jumped by 47.06% to $9.7 million in 2023, then grew by 3.71% to $10.1 million in 2024, then gained by 2.47% to $10.3 million in 2025, then decreased by 6.11% to $9.7 million in 2026.
• Per Business Quant, the three latest TELA Receivables figures stand at $9.7 million (Q1 2026), $10.3 million (Q4 2025), and $11.3 million (Q3 2025).